Literature DB >> 18846389

Human renal function maturation: a quantitative description using weight and postmenstrual age.

Malin M Rhodin1, Brian J Anderson, A Michael Peters, Malcolm G Coulthard, Barry Wilkins, Michael Cole, Etienne Chatelut, Anders Grubb, Gareth J Veal, Michael J Keir, Nick H G Holford.   

Abstract

This study pools published data to describe the increase in glomerular filtration rate (GFR) from very premature neonates to young adults. The data comprises measured GFR (using polyfructose, (51)Cr-EDTA, mannitol or iohexol) from eight studies (n = 923) and involved very premature neonates (22 weeks postmenstrual age) to adulthood (31 years). A nonlinear mixed effects approach (NONMEM) was used to examine the influences of size and maturation on renal function. Size was the primary covariate, and GFR was standardized for a body weight of 70 kg using an allometric power model. Postmenstrual age (PMA) was a better descriptor of maturational changes than postnatal age (PNA). A sigmoid hyperbolic model described the nonlinear relationship between GFR maturation and PMA. Assuming an allometric coefficient of 3/4, the fully mature (adult) GFR is predicted to be 121.2 mL/min per 70 kg [95% confidence interval (CI) 117-125]. Half of the adult value is reached at 47.7 post-menstrual weeks (95%CI 45.1-50.5), with a Hill coefficient of 3.40 (95%CI 3.03-3.80). At 1-year postnatal age, the GFR is predicted to be 90% of the adult GFR. Glomerular filtration rate can be predicted with a consistent relationship from early prematurity to adulthood. We propose that this offers a clinically useful definition of renal function in children and young adults that is independent of the predictable changes associated with age and size.

Entities:  

Mesh:

Year:  2008        PMID: 18846389     DOI: 10.1007/s00467-008-0997-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  48 in total

1.  Renal function in sick very low birthweight infants: 1. Glomerular filtration rate.

Authors:  B H Wilkins
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

2.  Assessing kidney function--measured and estimated glomerular filtration rate.

Authors:  Lesley A Stevens; Josef Coresh; Tom Greene; Andrew S Levey
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

3.  MATURATION OF RENAL FUNCTION IN CHILDHOOD: CLEARANCE STUDIES.

Authors:  M I Rubin; E Bruck; M Rapoport; M Snively; H McKay; A Baumler
Journal:  J Clin Invest       Date:  1949-09       Impact factor: 14.808

Review 4.  Does size matter? Clinical applications of scaling cardiac size and function for body size.

Authors:  Frederick E Dewey; David Rosenthal; Daniel J Murphy; Victor F Froelicher; Euan A Ashley
Journal:  Circulation       Date:  2008-04-29       Impact factor: 29.690

5.  Maturation and growth of renal function: dosing renally cleared drugs in children.

Authors:  W L Hayton
Journal:  AAPS PharmSci       Date:  2000

6.  Maturation of glomerular filtration in preterm and mature babies.

Authors:  M G Coulthard
Journal:  Early Hum Dev       Date:  1985-09       Impact factor: 2.079

7.  Of mice and men and elephants: metabolic rate sets glomerular filtration rate.

Authors:  M A Singer
Journal:  Am J Kidney Dis       Date:  2001-01       Impact factor: 8.860

8.  Expressing glomerular filtration rate in children.

Authors:  D C Heilbron; M A Holliday; A al-Dahwi; B A Kogan
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

9.  Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance.

Authors:  Brian J Anderson; Karel Allegaert; John N Van den Anker; Veerle Cossey; Nicholas H G Holford
Journal:  Br J Clin Pharmacol       Date:  2006-07-21       Impact factor: 4.335

10.  Creatinine and urea clearances compared to inulin clearance in preterm and mature babies.

Authors:  M G Coulthard; E N Hey; V Ruddock
Journal:  Early Hum Dev       Date:  1985-05       Impact factor: 2.079

View more
  164 in total

1.  Model-based approaches for ivabradine development in paediatric population, part I: study preparation assessment.

Authors:  Sophie Peigné; François Bouzom; Karl Brendel; Charlotte Gesson; Sylvain Fouliard; Marylore Chenel
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-11-12       Impact factor: 2.745

2.  Pharmacokinetics of ε-Aminocaproic Acid in Neonates Undergoing Cardiac Surgery with Cardiopulmonary Bypass.

Authors:  Michael P Eaton; George M Alfieris; Dawn M Sweeney; Ronald E Angona; Jill M Cholette; Charles Venuto; Brian Anderson
Journal:  Anesthesiology       Date:  2015-05       Impact factor: 7.892

3.  Amikacin maturation model as a marker of renal maturation to predict glomerular filtration rate and vancomycin clearance in neonates.

Authors:  Wei Zhao; Valérie Biran; Evelyne Jacqz-Aigrain
Journal:  Clin Pharmacokinet       Date:  2013-12       Impact factor: 6.447

Review 4.  Clinical pharmacology = disease progression + drug action.

Authors:  Nick Holford
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

5.  Developmental Pharmacokinetics and Age-Appropriate Dosing Design of Milrinone in Neonates and Infants with Acute Kidney Injury Following Cardiac Surgery.

Authors:  Tomoyuki Mizuno; Katja M Gist; Zhiqian Gao; Michael F Wempe; Jeffrey Alten; David S Cooper; Stuart L Goldstein; Alexander A Vinks
Journal:  Clin Pharmacokinet       Date:  2019-06       Impact factor: 6.447

6.  A Population and Developmental Pharmacokinetic Analysis To Evaluate and Optimize Cefotaxime Dosing Regimen in Neonates and Young Infants.

Authors:  Stéphanie Leroux; Jean-Michel Roué; Jean-Bernard Gouyon; Valérie Biran; Hao Zheng; Wei Zhao; Evelyne Jacqz-Aigrain
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

Review 7.  Considerations in the pharmacologic treatment and prevention of neonatal sepsis.

Authors:  Chris Stockmann; Michael G Spigarelli; Sarah C Campbell; Jonathan E Constance; Joshua D Courter; Emily A Thorell; Jared Olson; Catherine M T Sherwin
Journal:  Paediatr Drugs       Date:  2014-02       Impact factor: 3.022

8.  Population pharmacokinetics of tobramycin in patients with and without cystic fibrosis.

Authors:  Stefanie Hennig; Joseph F Standing; Christine E Staatz; Alison H Thomson
Journal:  Clin Pharmacokinet       Date:  2013-04       Impact factor: 6.447

9.  Evaluating renal function and age as predictors of amikacin clearance in neonates: model-based analysis and optimal dosing strategies.

Authors:  Sílvia M Illamola; Helena Colom; J G Coen van Hasselt
Journal:  Br J Clin Pharmacol       Date:  2016-06-30       Impact factor: 4.335

10.  Model-based approaches for ivabradine development in paediatric population, part II: PK and PK/PD assessment.

Authors:  Sophie Peigné; Sylvain Fouliard; Sophie Decourcelle; Marylore Chenel
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-11-14       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.